Revitalization, Reform Ahead for the FDA

被引：0

作者：

Wechsler, Jill

机构：

来源：

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：16 / +

页数：2

共 50 条

[1] Revitalization and reform in the year ahead
Wechsler, J
[J]. BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1996, 9 (01): : 16 - +
[2] FDA REFORM
MOSSINGHOFF, GJ
[J]. ISSUES IN SCIENCE AND TECHNOLOGY, 1992, 8 (02) : 22 - 23
[3] REFORM AT THE FDA
THERRE, H
[J]. BIOFUTUR, 1992, (110) : 46 - &
[4] FDA "reform"?
Miller, HI
[J]. SCIENCE, 1998, 279 (5348) : 158 - 159
[5] FDA reform
不详
[J]. JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (12) : 23N - 23N
[6] EDUCATION REFORM AS REVITALIZATION MOVEMENT
MUNCEY, DE
MCQUILLAN, PJ
[J]. AMERICAN JOURNAL OF EDUCATION, 1993, 101 (04) : 393 - 431
[7] US Senate passes FDA Revitalization Act
Guthrie, P.
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 177 (01) : 23 - 23
[8] Major changes ahead for FDA
Wechsler, J
[J]. BIOPHARM INTERNATIONAL-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2002, 15 (11): : 50 - +
[9] Reform at the FDA-In Need of Reform
Sharfstein, Joshua M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (02): : 123 - 124
[10] A proposal for FDA reform
Henry I. Miller
[J]. Nature Reviews Drug Discovery, 2002, 1 : 642 - 648